Sunesis Pharmaceuticals Gross Profit 2006-2020 | SNSS

Sunesis Pharmaceuticals gross profit from 2006 to 2020. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Sunesis Pharmaceuticals Annual Gross Profit
(Millions of US $)
2019 $2
2018 $0
2017 $1
2016 $3
2015 $3
2014 $6
2013 $8
2012 $4
2011 $5
2010 $0
2009 $4
2008 $5
2007 $10
2006 $14
2005 $17
Sunesis Pharmaceuticals Quarterly Gross Profit
(Millions of US $)
2020-03-31 $0
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31 $0
2017-12-31
2017-09-30
2017-06-30
2017-03-31 $1
2016-12-31 $1
2016-09-30 $1
2016-06-30 $1
2016-03-31 $1
2015-12-31 $1
2015-09-30 $1
2015-06-30 $1
2015-03-31 $1
2014-12-31 $1
2014-09-30 $1
2014-06-30 $2
2014-03-31 $2
2013-12-31 $2
2013-09-30 $2
2013-06-30 $2
2013-03-31 $2
2012-12-31 $2
2012-09-30 $0
2012-06-30 $2
2012-03-31
2011-12-31
2011-09-30 $1
2011-06-30
2011-03-31 $4
2010-12-31 $0
2010-09-30
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $4
2009-03-31 $0
2008-12-31 $0
2008-09-30 $1
2008-06-30 $3
2008-03-31 $2
2007-12-31 $2
2007-09-30 $2
2007-06-30 $3
2007-03-31 $3
2006-12-31 $2
2006-09-30 $2
2006-06-30 $7
2006-03-31 $3
2005-12-31 $5
2005-09-30 $3
2005-06-30 $5
2005-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.044B $0.002B
Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. It has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. It is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $129.932B 14.31
Gilead Sciences (GILD) United States $97.264B 12.61
CSL (CSLLY) Australia $92.662B 0.00
Vertex Pharmaceuticals (VRTX) United States $70.736B 48.63
Regeneron Pharmaceuticals (REGN) United States $65.850B 25.38
Illumina (ILMN) United States $52.685B 54.14
Biogen (BIIB) United States $48.899B 8.37
Seattle Genetics (SGEN) United States $26.040B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.104B 10.79
Moderna (MRNA) United States $22.492B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.519B 0.00
Incyte (INCY) United States $20.390B 0.00
BioMarin Pharmaceutical (BMRN) United States $19.442B 176.25
Genmab (GMAB) Denmark $18.912B 15.57
Genmab (GNMSF) Denmark $17.615B 52.30
Alnylam Pharmaceuticals (ALNY) United States $15.145B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
BeiGene (BGNE) Cayman Islands $13.265B 0.00
Galapagos (GLPG) Belgium $12.703B 37.62
Exact Sciences (EXAS) United States $12.698B 0.00
BioNTech SE (BNTX) Germany $11.313B 0.00
Sarepta Therapeutics (SRPT) United States $11.309B 0.00
ARGENX SE-ADR (ARGX) Netherlands $10.871B 0.00
QIAGEN (QGEN) Netherlands $10.103B 29.38
Bio-Techne Corp (TECH) United States $9.653B 63.78
Horizon Therapeutics Public (HZNP) Ireland $9.077B 22.34
Guardant Health (GH) United States $7.819B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.131B 0.00
Immunomedics (IMMU) United States $6.969B 0.00
Ascendis Pharma (ASND) Denmark $6.934B 0.00
Exelixis (EXEL) United States $6.924B 24.28
Repligen (RGEN) United States $6.372B 111.76
Adaptive Biotechnologies (ADPT) United States $4.974B 0.00
Acceleron Pharma (XLRN) United States $4.957B 0.00
MyoKardia (MYOK) United States $4.613B 0.00
Emergent Biosolutions (EBS) United States $4.447B 29.15
China Biologic Products (CBPO) China $4.316B 23.99
Reata Pharmaceuticals (RETA) United States $4.305B 0.00
MorphoSys AG (MOR) Germany $4.199B 32.57
Ultragenyx Pharmaceutical (RARE) United States $4.170B 0.00
Zai Lab (ZLAB) China $4.167B 0.00
Mirati Therapeutics (MRTX) United States $4.077B 0.00
Vir Biotechnology (VIR) United States $4.010B 0.00
Global Blood Therapeutics (GBT) United States $3.949B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.885B 84.89
Blueprint Medicines (BPMC) United States $3.767B 0.00
Bluebird Bio (BLUE) United States $3.723B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.539B 0.00
Amicus Therapeutics (FOLD) United States $3.301B 0.00
Arena Pharmaceuticals (ARNA) United States $3.290B 0.00
Halozyme Therapeutics (HALO) United States $3.159B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.999B 0.00
NeoGenomics (NEO) United States $2.899B 211.69
Denali Therapeutics (DNLI) United States $2.852B 0.00
UniQure (QURE) Netherlands $2.719B 0.00
Alkermes (ALKS) Ireland $2.672B 52.59
Viela Bio (VIE) United States $2.619B 0.00
Amarin (AMRN) Ireland $2.606B 0.00
Novavax (NVAX) United States $2.588B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.516B 0.00
Insmed (INSM) United States $2.479B 0.00
Alector (ALEC) United States $2.396B 0.00
Fate Therapeutics (FATE) United States $2.334B 0.00
Principia Biopharma (PRNB) United States $1.986B 0.00
Ligand Pharmaceuticals (LGND) United States $1.924B 74.94
Eidos Therapeutics (EIDX) United States $1.891B 0.00
Inovio Pharmaceuticals (INO) United States $1.878B 0.00
Epizyme (EPZM) United States $1.729B 0.00
Zymeworks (ZYME) Canada $1.648B 0.00
Adverum Biotechnologies (ADVM) United States $1.628B 0.00
Sangamo Therapeutics (SGMO) United States $1.582B 0.00
Twist Bioscience (TWST) United States $1.510B 0.00
Mesoblast (MESO) Australia $1.496B 0.00
Akcea Therapeutics (AKCA) United States $1.496B 0.00
PHARMA MAR SA (PHMMF) Spain $1.494B 0.00
Editas Medicine (EDIT) United States $1.487B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.482B 0.00
Zealand Pharma (ZEAL) Denmark $1.464B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.446B 0.00
Intra-Cellular Therapies (ITCI) United States $1.420B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Beam Therapeutics (BEAM) United States $1.405B 0.00
Arcus Biosciences (RCUS) United States $1.384B 0.00
REGENXBIO (RGNX) United States $1.375B 0.00
I-Mab (IMAB) China $1.361B 0.00
Mersana Therapeutics (MRSN) United States $1.335B 0.00
Coherus BioSciences (CHRS) United States $1.329B 9.28
NGM Biopharmaceuticals (NGM) United States $1.326B 0.00
Arvinas (ARVN) United States $1.287B 0.00
Revance Therapeutics (RVNC) United States $1.218B 0.00
Cytokineticsorporated (CYTK) United States $1.192B 0.00
Myriad Genetics (MYGN) United States $1.187B 61.23
Intellia Therapeutics (NTLA) United States $1.060B 0.00
Compugen (CGEN) Israel $1.007B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.979B 0.00
Athenex (ATNX) United States $0.971B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.924B 0.00
Pharming Group (PHGUF) Netherlands $0.882B 0.00
Heska (HSKA) United States $0.841B 0.00
Sorrento Therapeutics (SRNE) United States $0.809B 0.00
Cue Biopharma (CUE) United States $0.763B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.750B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.750B 0.00
Cara Therapeutics (CARA) United States $0.731B 0.00
Kala Pharmaceuticals (KALA) United States $0.729B 0.00
Codexis (CDXS) United States $0.726B 0.00
Cellectis S.A (CLLS) France $0.723B 0.00
NextCure (NXTC) United States $0.720B 0.00
Morphic Holding (MORF) United States $0.711B 0.00
Kadmon Holdings (KDMN) United States $0.699B 0.00
Retrophin (RTRX) United States $0.681B 0.00
Alcobra (ARCT) United States $0.668B 0.00
Vericel (VCEL) United States $0.657B 121.33
ZIOPHARM Oncology Inc (ZIOP) United States $0.654B 0.00
Castle Biosciences (CSTL) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Vanda Pharmaceuticals (VNDA) United States $0.626B 5.36
Stemline Therapeutics (STML) United States $0.625B 0.00
Agenus (AGEN) United States $0.625B 0.00
Bellus Health (BLU) Canada $0.625B 0.00
NantKwest (NK) United States $0.612B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.606B 0.00
Dynavax Technologies (DVAX) United States $0.597B 0.00
Frequency Therapeutics (FREQ) United States $0.584B 0.00
DBV Technologies S.A (DBVT) France $0.568B 0.00
Athersys (ATHX) United States $0.556B 0.00
UROGEN PHARMA (URGN) United States $0.555B 0.00
Intrexon (PGEN) United States $0.551B 0.00
MeiraGTx Holdings (MGTX) United States $0.538B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.524B 0.00
Cel-Sci (CVM) United States $0.515B 0.00
AnaptysBio (ANAB) United States $0.509B 0.00
Clovis Oncology (CLVS) United States $0.498B 0.00
Anika Therapeutics (ANIK) United States $0.493B 15.86
VBI Vaccines (VBIV) United States $0.484B 0.00
BioDelivery Sciences (BDSI) United States $0.474B 24.95
Scholar Rock Holding (SRRK) United States $0.472B 0.00
Merus (MRUS) Netherlands $0.469B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.468B 0.00
AC Immune SA (ACIU) Switzerland $0.448B 0.00
Protagonist Therapeutics (PTGX) United States $0.445B 0.00
Prothena (PRTA) Ireland $0.435B 0.00
Puma Biotechnology (PBYI) United States $0.415B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.414B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.409B 0.00
Syros Pharmaceuticals (SYRS) United States $0.393B 0.00
PDL BioPharma (PDLI) United States $0.387B 332.00
Albireo Pharma (ALBO) United States $0.386B 0.00
Avid Bioservices (CDMO) United States $0.383B 0.00
MiMedx (MDXG) United States $0.382B 0.00
ANI Pharmaceuticals (ANIP) United States $0.375B 7.44
CytomX Therapeutics (CTMX) United States $0.375B 0.00
Precision BioSciences (DTIL) United States $0.371B 0.00
Kamada (KMDA) Israel $0.348B 14.49
Seres Therapeutics (MCRB) United States $0.345B 0.00
OSMOTICA PHARM (OSMT) United States $0.344B 0.00
Selecta Biosciences (SELB) United States $0.332B 0.00
WAVE Life Sciences (WVE) Singapore $0.326B 0.00
Geron (GERN) United States $0.313B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.307B 0.00
MannKind (MNKD) United States $0.303B 0.00
Menlo Therapeutics (MNLO) United States $0.301B 0.00
Verastem (VSTM) United States $0.297B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.296B 0.00
ChromaDex (CDXC) United States $0.281B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.273B 0.00
Pfenex (PFNX) United States $0.269B 0.00
Liquidia Technologies (LQDA) United States $0.268B 0.00
ADMA Biologics Inc (ADMA) United States $0.268B 0.00
Starpharma Holdings (SPHRY) Australia $0.266B 0.00
Cellular Biomedicine (CBMG) United States $0.256B 0.00
Affimed (AFMD) Germany $0.252B 0.00
Spero Therapeutics (SPRO) United States $0.250B 0.00
HOOKIPA Pharma (HOOK) United States $0.250B 0.00
Gritstone Oncology (GRTS) United States $0.243B 0.00
Exicure (XCUR) United States $0.243B 0.00
Abeona Therapeutics (ABEO) United States $0.243B 0.00
Prometic Life Sciences (LMNL) Canada $0.242B 0.00
Northwest Biotherapeutics (NWBO) United States $0.240B 0.00
Fortress Biotech (FBIO) United States $0.238B 0.00
XOMA (XOMA) United States $0.238B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
POXEL SA FRANCE (PXXLF) France $0.217B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.202B 3.05
Paratek Pharmaceuticals (PRTK) United States $0.201B 0.00
IBio (IBIO) United States $0.200B 0.00
IVERIC Bio (ISEE) United States $0.200B 0.00
GENFIT S.A (GNFT) France $0.199B 0.00
Pluristem Therapeutics (PSTI) Israel $0.196B 0.00
ARAVIVE, INC (ARAV) United States $0.195B 0.00
VTv Therapeutics (VTVT) United States $0.195B 0.00
TELA Bio (TELA) United States $0.194B 0.00
Aduro Biotech (ADRO) United States $0.191B 0.00
Kindred Biosciences (KIN) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.182B 0.00
Aytu Bioscience (AYTU) United States $0.176B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.173B 0.00
Five Prime Therapeutics (FPRX) United States $0.172B 0.00
Celyad SA (CYAD) Belgium $0.171B 0.00
Orgenesis (ORGS) United States $0.169B 0.00
Aptinyx (APTX) United States $0.168B 0.00
Dyadic (DYAI) United States $0.164B 0.00
Cyclerion Therapeutics (CYCN) United States $0.161B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Cerecor (CERC) United States $0.158B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
PHASEBIO PHARMA (PHAS) United States $0.145B 0.00
Trevena (TRVN) United States $0.143B 0.00
Arbutus Biopharma (ABUS) Canada $0.141B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Palatin Technologies (PTN) United States $0.135B 3.45
CorMedix Inc (CRMD) United States $0.134B 0.00
VolitionRX (VNRX) United States $0.133B 0.00
Theratechnologies (THTX) Canada $0.132B 0.00
Applied Genetic Technologies (AGTC) United States $0.131B 0.00
Enzo Biochem (ENZ) United States $0.126B 0.00
Antibe Therapeutics (ATBPF) Canada $0.119B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.118B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
Lumos Pharma (LUMO) United States $0.114B 0.00
AIT Therapeutics (XAIR) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.111B 0.00
Checkpoint Therapeutics (CKPT) United States $0.110B 0.00
Eton Pharmaceuticals (ETON) United States $0.108B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.101B 0.00
Windtree Therapeutics (WINT) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.094B 0.00
AquaBounty Technologies (AQB) United States $0.089B 0.00
Organovo Holdings (ONVO) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.084B 0.00
SESEN BIO, INC (SESN) United States $0.084B 0.00
Celsion (CLSN) United States $0.084B 0.00
Adocia (ADOCY) France $0.080B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Proteostasis Therapeutics (PTI) United States $0.075B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Stealth BioTherapeutics (MITO) United States $0.071B 0.00
DiaMedica Therapeutics (DMAC) United States $0.068B 0.00
Happiness Biotech Group (HAPP) China $0.068B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.060B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.058B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Apricus Biosciences (SEEL) United States $0.051B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.050B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.047B 0.00
Signal Genetics (MGEN) United States $0.046B 0.00
Advaxis (ADXS) United States $0.046B 0.00
Prima BioMed (IMMP) Australia $0.043B 0.00
TrovaGene (CRDF) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
OvaScience (MLND) United States $0.042B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Titan Pharmaceuticals (TTNP) United States $0.034B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Curis (CRIS) United States $0.031B 0.00
TOCAGEN INC (TOCA) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Novogen (KZIA) Australia $0.022B 0.00
VIVUS (VVUS) United States $0.019B 0.00
Aptevo Therapeutics (APVO) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Unum Therapeutics (UMRX) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00